MedStar Health partners with Indivumed for precision oncology database

Columbia, Md.-based MedStar Health will collaborate with Indivumed, a Hamburg, Germany-based oncology research company, to advance precision medicine treatments.

Under the multi-year partnership, MedStar will collect breast, lung and pancreatic biospecimens, among other cancer tissues, from select cancer programs at various hospitals in the MedStar Health Cancer Network. Researchers will be able to analyze these biospecimens to develop personalized cancer treatments for patients.

The partnership will also enable MedStar researchers to access existing biospecimens and clinical samples housed in Indivumed's cancer database, which comprise data contributed by more than 30,000 patients in Europe, Asia and the United States.

More articles on health IT:
Report: 5 best, worst states for EHR adoption
Philips opens 'innovation center' in Pittsburgh
Meditech revenue dips 3% in Q2: 4 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months